Literature DB >> 24402113

Acute nephrotoxicity of cisplatin: molecular mechanisms.

Luis Alberto Batista Peres, Ademar Dantas da Cunha.   

Abstract

The nephrotoxic drugs have been responsible for about 20% of AKI episodes in inpatients and outpatients. The cisplatin nephrotoxicity is a major limiting factors in 20% of patients who have received the drug, triggering injuries in renal tubular epithelial cells. Cisplatin toxicity is determined by the target tissue and cells accumulation besides the interaction with various subcellular structures and macromolecules. Cisplatin accumulates and interferes with the functioning of different organelles such as mitochondria, lysosomes, endoplasmic reticulum, nuclei and cell membranes, causing inflammation and cell death. This review aims to define the pathophysiology and biochemistry of the cisplatin nephrotoxicity, reviewing the main molecular mechanisms that lead to tubular cisplatin toxicity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24402113     DOI: 10.5935/0101-2800.20130052

Source DB:  PubMed          Journal:  J Bras Nefrol        ISSN: 0101-2800


  67 in total

1.  Cytotoxic effect of Erythroxylum daphnites extract is associated with G1 cell cycle arrest and apoptosis in oral squamous cell carcinoma.

Authors:  Silvia T Elias; Carolina C S Macedo; Luiz A Simeoni; Dâmaris Silveira; Pérola O Magalhães; Adriana Lofrano-Porto; Ricardo D Coletta; Francisco A R Neves; Eliete N S Guerra
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

2.  Perindopril regulates the inflammatory mediators, NF-κB/TNF-α/IL-6, and apoptosis in cisplatin-induced renal dysfunction.

Authors:  Abdel-Gawad S Shalkami; Mohamed I A Hassan; Ahmed A Abd El-Ghany
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-07-31       Impact factor: 3.000

3.  Nephroprotective efficacy of ceftriaxone against cisplatin-induced subchronic renal fibrosis in rats.

Authors:  Mohamed M Abdel-Daim; Yasser S El-Sayed; Mabrouk Abd Eldaim; Abdelazim Ibrahim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-12-14       Impact factor: 3.000

4.  Cutaneous exposure to lewisite causes acute kidney injury by invoking DNA damage and autophagic response.

Authors:  Ritesh K Srivastava; Amie M Traylor; Changzhao Li; Wenguang Feng; Lingling Guo; Veena B Antony; Trenton R Schoeb; Anupam Agarwal; Mohammad Athar
Journal:  Am J Physiol Renal Physiol       Date:  2018-01-17

5.  Loss of α(E)-catenin promotes Fas mediated apoptosis in tubular epithelial cells.

Authors:  Xinhui Wang; Alan R Parrish
Journal:  Apoptosis       Date:  2015-07       Impact factor: 4.677

6.  Prevention of renal dysfunction by nutraceuticals prepared from oil rich plant foods.

Authors:  Sahar Y Al-Okbi; Doha A Mohamed; Thanaa E Hamed; Reham Sh Esmail; Souria M Donya
Journal:  Asian Pac J Trop Biomed       Date:  2014-08

7.  MicroRNA-709 Mediates Acute Tubular Injury through Effects on Mitochondrial Function.

Authors:  Yan Guo; Jiajia Ni; Shuang Chen; Mi Bai; Jiajuan Lin; Guixia Ding; Yue Zhang; Pingping Sun; Zhanjun Jia; Songming Huang; Li Yang; Aihua Zhang
Journal:  J Am Soc Nephrol       Date:  2017-10-17       Impact factor: 10.121

Review 8.  Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications.

Authors:  Jacek Zielonka; Joy Joseph; Adam Sikora; Micael Hardy; Olivier Ouari; Jeannette Vasquez-Vivar; Gang Cheng; Marcos Lopez; Balaraman Kalyanaraman
Journal:  Chem Rev       Date:  2017-06-27       Impact factor: 60.622

9.  Celastrol pretreatment as a therapeutic option against cisplatin-induced nephrotoxicity.

Authors:  Tugce Boran; Aysenur Gunaydin; Ayse Tarbin Jannuzzi; Eren Ozcagli; Buket Alpertunga
Journal:  Toxicol Res (Camb)       Date:  2019-07-31       Impact factor: 3.524

10.  Proximal tubule-targeted heme oxygenase-1 in cisplatin-induced acute kidney injury.

Authors:  Subhashini Bolisetty; Amie Traylor; Reny Joseph; Abolfazl Zarjou; Anupam Agarwal
Journal:  Am J Physiol Renal Physiol       Date:  2015-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.